Access Bio has ranked among the top searched stocks for 13 days in the past month.
As of 1:30 PM on the 22nd, Access Bio is trading at 28,600 KRW, down 4.83% from the previous day. This represents an 18.63% decline compared to October 12. Access Bio is known as a specialized manufacturer of in vitro diagnostic products, including malaria diagnostic kits.
Over the past five days, individual investors have net purchased 6,278 shares, while foreigners and institutions have net sold 9,709 shares and net purchased 1,700 shares, respectively.
On October 13, Access Bio became a market issue with a sharp rise following the "U.S. approval of the COVID-19 diagnostic kit."
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
